# Study of Tesetaxel in Japanese Patients With Solid Tumors

> **NCT01337310** · PHASE1 · UNKNOWN · sponsor: **Genta Incorporated** · enrollment: 12 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Tesetaxel

## Key facts

- **NCT ID:** NCT01337310
- **Lead sponsor:** Genta Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2012-07
- **Final completion:** 2012-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337310, "Study of Tesetaxel in Japanese Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01337310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*